Everolimus slows disease progression in advanced kidney cancer patients
Friday, September 27, 2013 - 22:30
in Health & Medicine
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease.